Ackrell Capital Report Highlights Funding Gap and Investor Activity in Cannabis Industry
Summary
The passage provides market analysis and investment trends in the cannabis sector but lacks specific allegations, names of high‑profile officials, or actionable misconduct leads. It mentions corporate Cannabis companies raised over $2 billion in 2017, mostly from retail and family‑office investors. Strategic investors such as Constellation Brands and Scotts Miracle‑Gro have made notable investment
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Cannabis Investment Report – Market Overview and Strategic Investor Activity (Dec 2017)
The passage provides a generic industry analysis and mentions corporate investments by publicly traded firms, but lacks specific allegations, financial flow details, or connections to high‑level polit Constellation Brands invested ~US$190 M in Canopy Growth. Scotts Miracle‑Gro spent >US$400 M acquiring cannabis‑related supply firms. 300+ cannabis‑related companies trade globally, many on OTC marke
Industry overview of cannabis and hemp companies with revenue and partnership details
The passage provides commercial financial metrics and partnership information for several cannabis‑related firms. It contains no references to high‑ranking officials, government agencies, or illicit a GTI reports $41.7 M revenue with >300% YoY growth. Khiron Life Sciences entered a 50/50 JV with U.S. Dixie Brands for Latin American CBD cosmetics. Level Brands acquired CBD consumer brand cbdMD, gen
Cannabis Investment Report – December 2017 Overview of Distribution and Regulatory Landscape
The passage is a generic industry analysis without specific names, transactions, dates, or concrete allegations involving high‑profile officials or entities. It offers only broad context about tax and Highlights tax compliance risks for cannabis distributors across U.S. states. Notes potential market saturation and licensing moratoriums in Colorado. Mentions California’s new cannabis regulatory ag
Cannabis Investment Report shows stock gains tied to political announcements
The passage merely reports market performance linked to publicly known political events (Trudeau's legalization plan, Trump election, Sessions appointment) and a corporate investment. It offers no con Canadian cannabis stocks rose after Prime Minister Justin Trudeau announced recreational legalizatio U.S. cannabis stocks remained resilient despite Donald Trump's election and Jeff Sessions as Attor
Cannabis Investment Report – Projected International Legal Market Values (Dec 2017)
The passage provides market size estimates for legal cannabis markets worldwide. It contains no references to political figures, government agencies, financial misconduct, or illicit flows. While it c Lists projected market values for 20+ countries based on 20% penetration and spending estimates. Sources data from Ackrell Capital, a FINRA‑registered firm. Includes adult population and average mont
Synthetic biology and QA/QC testing market for cannabinoids
The passage is a commercial market analysis describing production methods and testing opportunities for CBD. It mentions no high‑profile officials, agencies, or controversial financial flows, and prov Synthetic biology can produce cannabinoids via fermentation. QA/QC testing standards for CBD are currently fragmented across states. Life‑science instrument makers (Agilent, Danaher, PerkinElmer, Shi
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.